A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
about
Nicotine receptor partial agonists for smoking cessationFlexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trialSmoking cessation and reduction in people with chronic mental illnessSmoking Use and Cessation Among People with Serious Mental IllnessThe human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and functionRisk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysisThe Past, Present, and Future of Nicotine Addiction TherapyVarenicline as a Cause of Suicidal OutcomesVarenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawalAddressing Smoking in Supported Residential Facilities for People with Severe Mental Illness: Has Any Progress Been Achieved?Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinicsSmoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.Strategies to help a smoker who is struggling to quitImpact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study.Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.E-cigarette use among smokers with serious mental illness.Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.Tobacco use and cessation for cancer survivors: an overview for cliniciansVarenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.Smoking cessation in Asians: focus on vareniclineProtocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesitTreatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practicesVarenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.A Review of Smoking Cessation in Bipolar Disorder: Implications for Future ResearchInterventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.The use of peer mentors to enhance a smoking cessation intervention for persons with serious mental illnesses.Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.Pharmacotherapies for COPD.Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use DisordersTreatment of tobacco dependence in people with mental health and addictive disorders.Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trialVarenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline.Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systemsGoing up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.Smoking and mental illness. An update for psychiatrists.Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.
P2860
Q24185773-8542C0E5-E90A-4503-9CF3-D259F0BC8110Q24658591-FD27B054-8F3A-4C4E-997D-1AC752BB7D8CQ26782639-50A6F37F-E484-41C1-BAB6-D47E39D647C4Q26785461-4DF09714-D66A-4F62-800A-282A49CFAB4BQ26821785-71822F46-7D2E-4877-95EA-BF55E80968B3Q28083649-C10C5D56-C0D1-4CFE-9E84-3A95DEA0BE74Q28088508-CC9E9A3D-55AF-4962-B69D-D76EAABB5C7EQ28255130-520060F3-86EB-47FF-8344-0AB19C790279Q28552053-8BC0A557-917C-42A2-931A-09F77466A5A4Q30362464-5D3ACA7B-198E-4352-BF39-F56C317BC4E7Q30433175-BFC725D3-0C66-41CB-96AC-9771BA800FB5Q30826920-92A8F711-6D8C-4DCF-8229-2F64D384ECF6Q33582051-48F8EECA-E435-428F-97E3-329ADE99368DQ33854297-7ED386C8-2591-48D7-9595-F3B1577847AEQ33909736-0785D531-DFB0-4CC7-A737-9A3F57F2D90FQ34014716-95604846-56E8-450D-8F13-053B996B7592Q34306544-4353BE14-5B9F-4FCD-8BDE-E07E74F5BA6CQ34324912-53288282-F110-4FA1-A51C-A84AF088F575Q34470456-60D35D02-F5F8-4CF3-8957-16CB6793BCA4Q34565619-58D3758C-71C6-4CE7-A157-082A5191F455Q34992065-EF712AF2-B572-41D5-9AAA-14F5CACD19D8Q35226577-FFF10A25-561B-46E8-9A4D-7213E87537F4Q35302795-346A0573-ED3E-4E0A-8B4D-0F01D5025E6BQ35491463-4AC90A68-B901-4B65-B2C8-9487E262ECF8Q35700367-925C4E34-9399-4C7D-AA12-2D639928EA87Q35701489-9BB5F9F0-A724-4C48-95A8-01A141A2565CQ35931738-77C106B4-6791-4EC8-9FEF-9FE6B972F8F7Q36041822-485D4F04-1725-4C4B-8D5E-75D8144D2839Q36377890-91C4A992-A21C-4B63-9C6F-647769333F97Q36689666-B291CA1F-1ECE-4594-8739-04C660C801ACQ36711713-ECD564CC-FB0F-4C86-ACC6-8280233AA556Q36843717-99F0F03F-F7E9-43F2-94C4-804B2EFABBC4Q36927085-43E8E6CF-6319-4A76-9BFA-9F830FFB4C15Q37043526-ABC29DF1-848A-49E6-82A3-886F2E6176C1Q37184340-DEB60041-57ED-4C52-AAD2-30722374876DQ37567657-41C1D609-BDD4-4D51-B497-6D62943F54FDQ38122913-339C2D22-D224-40E7-B56C-60D68A075ADFQ38171876-061DA987-5586-46E6-AC7D-B284A31EFD7AQ38290164-A2B21923-A824-4D53-A127-D1E48B1F8238Q38395288-01BF78D7-B106-4E22-9BBC-A3DFA79BE0BB
P2860
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
type
label
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
prefLabel
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
P2093
P356
P1476
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
P2093
Carla Yunis
Chad D Morris
Jill M Williams
Joan Treadow
John R Thompson
Robert M Anthenelli
Tony P George
P304
P356
10.4088/JCP.11M07522
P577
2012-05-01T00:00:00Z